Clinical Trial Update: Efficacy and Safety of Oxycodone/Naloxone (Targin®) in Persistent Moderate to Severe Low Back Pain Following NSAIDs Treatment [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update assessing efficacy and safety of oxycodone/naloxone (Targin®) for persistent moderate to severe low back pain after NSAID treatmen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low Back Pain

Drugs mentioned

• TARGIN (oxycodone/naloxone)

Snippet

Sponsor: Mundipharma Korea Ltd | Conditions: Low Back Pain | Phase 4 | Status: COMPLETED